Family Offices Back $155M Atlas Seed Round - InforCapital

Atlas, a trailblazer in DNA-based data storage technology, has announced a $155 million seed funding round, attracting high-profile backing from family offices Tao Capital Partners and Bezos Expeditions. This substantial capital injection underscores a growing belief in synthetic biology as the foundation for next-generation data infrastructure.

Bezos Expeditions is Jeff Bezos' investment firm that manages a broad portfolio across multiple industries. Tao Capital Partners is the direct-investment family office of Nicholas J. Pritzker and his son Joby Pritzker, members of the Hyatt Hotels branch of the Pritzker family.

The funding round also included participation from other top-tier investors such as ARCH Venture Partners, Deerfield Management, Rsquared VC, Earth Foundry, In-Q-Tel (IQT), and other undisclosed investors. This diverse investor pool demonstrates wide-reaching confidence in Atlas’s potential to disrupt the data storage sector with sustainable, scalable, and ultra-dense technology.

As part of its launch, Atlas has acquired key DNA storage assets from Twist Bioscience, a move that propels it into a leading position within this emerging field. With this acquisition, Atlas is now equipped to commercialize DNA-based storage systems that boast unmatched density, durability, and efficiency.

At the heart of Atlas’s solution is a proprietary platform that merges semiconductor innovation with enzyme engineering. This allows the company to conduct massive parallel chemical processes on a chip, significantly reducing power consumption compared to traditional data centers and paving the way for greener cloud infrastructure.

Atlas is led by CEO Varun Mehta, founder of Nimble Storage, and CTO Bill Banyai, co-founder of Twist Bioscience. The leadership team is rounded out by Executive Chairman George Kadifa, an industry veteran with experience at Silver Lake, Hewlett-Packard, and IBM.

The company plans to deliver advanced storage products designed for hyperscalers, government institutions, and enterprise-level clients. Its offerings aim to meet the exploding data demands of the AI era while minimizing environmental impact.

Twist Bioscience retains a minority stake in Atlas, enabling both companies to focus on their respective strengths while jointly advancing the commercialization of DNA-based storage.

With robust support from strategic investors, Atlas is poised to redefine how the world stores and accesses data—one strand of DNA at a time.